Tonix Pharmaceuticals Holding Corp. (TNXP)

Tonix Announces Positive Pre-NDA Meeting – NDA Submission On Schedule


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
June 21, 2024
Report ID: 26818
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

Ticker
TNXP
Current Price
$0.527 -7.19%
Market Cap
$1.6M
Price Target
Refer to Report
Volume
11.6M
52wk Range
$0.5409 - $58.24
Related Research Reports
6/21/2024

Tonix Announces Positive Pre-NDA Meeting – NDA Submission On Schedule
Tonix Announces Positive Pre-NDA Meeting – NDA Submission On Schedule (TNXP)
5/31/2024

Tonmya Presentations From Previous and Upcoming Trials
Tonmya Presentations From Previous and Upcoming Trials (TNXP)
4/11/2024

Increasing The Focus on Fibromyalgia
Increasing The Focus on Fibromyalgia (TNXP)
12/21/2023

Fibromyalgia Trial Meets All Endpoints
Fibromyalgia Trial Meets All Endpoints (TNXP)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy